Novel B-Cell Depleting Targeted Therapies to Improve Outcomes in Patients With Sjögren’s Disease

This activity was supported by an educational grant from Novartis. Please go to ⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠ https://academiccme.com/courses/CCRSjDPod/ and complete the evaluation to receive your CE/CME Credit. Credit is available through June 7, 2027